REUTERS: Heart valve systems from Edwards Lifesciences Corp and Medtronic Plc have been approved for use in a condition that restricts blood flow ...
REUTERS: Heart valve systems from Edwards Lifesciences Corp and Medtronic Plc have been approved for use in a condition that restricts blood flow from the heart in patients at low-risk of death linked to open-heart surgeries, the FDA said on Friday.
Shares of Edwards Lifesciences rose 2.2per cent to US$219.9 in afternoon trading, while Medtronic's stock gained 1per cent to US$102.9.The heart valves were previously approved for patients at intermediate or higher risk of death or major complications during open-heart surgeries to replace damaged valves in patients with aortic stenosis.
The condition occurs when the heart's aortic valve narrows, restricting blood flow from the organ into the main artery carrying blood to the rest of the body. The latest approval expands the number of patients who can be treated with this less invasive procedure for aortic valve replacement, the health agency said.
The agency on Friday approved two of Edwards' transcatheter heart valve systems called Sapien 3 And Sapien 3 Ultra, while backing Medtronic's Evolut Transcatheter Aortic Valve Replacement system.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Roche's personalized cancer treatment wins FDA approvalThe U.S. Food and Drug Administration approved Roche Holding AG's personalized cancer treatment, the agency said on Thursday.
Read more »
FDA proposes new health warnings on cigarette packetsThe U.S. Food and Drug Administration on Thursday proposed new health warnings for cigarette packages and advertisements that it said could be the ...
Read more »
US FDA proposes graphic warnings on cigarette packs, advertisementsThe U.S. Food and Drug Administration on Thursday proposed new health warnings for cigarette packages and advertisements that it said could be the ...
Read more »
FDA approves Celgene's bone marrow cancer treatmentREUTERS: The U.S. Food and Drug Administration said on Friday it had approved Celgene Corp's treatment, Inrebic, for certain forms of bone marrow ...
Read more »
FDA approves AbbVie's new rheumatoid arthritis drugThe U.S. Food and Drug Administration on Friday approved AbbVie Inc's new treatment for rheumatoid arthritis, a win for the drugmaker seeking to ...
Read more »
FCC chairman circulates order to approve Sprint, T-Mobile tie-upWASHINGTON: U.S. Federal Communications Commission Chairman Ajit Pai on Wednesday circulated a draft order that would grant approval to the US$26 ...
Read more »